The Board remands the claim for service connection of monoclonal gammopathy of undetermined significance (MGUS) to ensure a new TERA opinion is obtained, addressing specific toxic exposures and their potential impact on MGUS.
The deciding factor: The February 2024 and July 2025 VA opinions were found inadequate due to insufficient consideration of exposure details and lack of rationale supporting unfavorable conclusions.
- Claimed conditions
- Monoclonal gammopathy of undetermined significance (MGUS)
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- November 28, 2025
- Citation
- A25102758
Veterans Law Judge
Decisions by this judge: 1,081 · Granted: 38% (granted or partly granted, in the vetted decisions on this site)
Judge attribution: 2025 complete; earlier years partial.
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation A25102758.
What this means for you
A remand is not a loss. The Board sent the case back for more development — often a new exam or missing records — before making a final decision. Many remands later end in a grant, and the decision spells out exactly what the Board wanted to see.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Denied
The Veteran's claim for a compensable rating for monoclonal gammopathy of undetermined significance (MGUS) is denied. The claim for service connection for bone cancer is also denied.
- Remanded (sent back)
The Board has decided to remand the claims for MGUS and right knee disability due to a lack of examinations, which may provide additional evidence on the etiology of these conditions.
- Denied
The Veteran's service-connected monoclonal gammopathy of undetermined significance (MGUS) has not manifested to symptomatic multiple myeloma, and thus does not warrant a compensable rating.
- Remanded (sent back)
The Board has remanded the case for a medical opinion regarding whether the Veteran's MGUS is related to herbicide agent exposure, and also for a determination on an initial compensable rating for MGUS.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.